List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 33 studies with search of: Arbovirus | Open Studies
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated
Condition: Rift Valley Fever
Intervention: Biological: Inactivated, Dried (TSI-GSD 200), RVF Vaccine
2 Not yet recruiting Diagnosis and Characterization of Dengue Fever in Children
Condition: Dengue Fever
Intervention:
3 Recruiting Treatment of Japanese Encephalitis
Condition: Japanese Encephalitis
Intervention: Drug: Ribavirin
4 Recruiting Characterization of Humoral and Cellular Immunity of Low and High-Responders After Tick-Borne Encephalitis (TBE) Vaccination
Condition: Tick-Borne Encephalitis
Intervention: Biological: TBE vaccination and influenza vaccination
5 Recruiting Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling
Condition: Japanese Encephalitis
Intervention: Biological: Japanese Encephalitis vaccine
6 Recruiting A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-borne Encephalitis (TBE) for NIAID Workers Manipulating Tick Borne Encephalitis Virus (TBEV) in the Laboratory
Conditions: Tick-Borne Encephalitis;   Encephalitis, Tick-Borne;   Tick-Borne Disease;   Glycoprotein E, Flavivirus;   NSI Protein, Flavivirus
Intervention: Biological: FSME-IMMUN 0.5ml Baxter
7 Not yet recruiting Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic Countries
Condition: Encephalitis
Intervention: Biological: IC51
8 Not yet recruiting Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults
Condition: West Nile Fever
Interventions: Biological: WN/DEN4delta30 vaccine;   Biological: Placebo
9 Not yet recruiting Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population
Condition: Encephalitis
Interventions: Biological: IC51 Japanese Encephalitis;   Biological: Havrix®720;   Biological: Prevnar
10 Recruiting Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR
Conditions: Malaria;   Dengue;   Japanese Encephalitis
Interventions: Drug: 20% deet insect repellent;   Drug: placebo control
11 Not yet recruiting Postencephalitic Symptoms After Tick Borne Encephalitis
Condition: Central European Encephalitis
Intervention:
12 Recruiting Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine
Condition: Venezuelan Equine Encephalomyelitis
Intervention: Biological: VEE TC-83
13 Recruiting Safety and Immunogenicity Study of Eastern Equine Encephalitis (EEE) Vaccine
Condition: Eastern Equine Encephalitis
Intervention: Biological: Inactivated, Dried, TSI-GSD 104, EEE
14 Not yet recruiting Adult Dengue Platelet Study
Condition: Dengue Fever
Interventions: Procedure: Platelet transfusion;   Procedure: Supportive care
15 Recruiting Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31‐7164) in Healthy Adults
Condition: Dengue Fever
Intervention: Biological: rDEN3delta30/31‐7164
16 Recruiting Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine
Condition: Dengue Fever
Interventions: Biological: rDEN2/4delta30(ME) vaccine;   Biological: Placebo
17 Recruiting Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus
Condition: Dengue Hemorrhagic Fever
Interventions: Biological: rDEN1delta30;   Biological: rDEN2/4delta30(ME);   Biological: Placebo to rDEN1delta30 or rDEN2/4delta30(ME)
18 Recruiting Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy Adults
Condition: Dengue
Interventions: Biological: rDEN3/4delta30(ME);   Biological: Placebo
19 Recruiting The Effect of Extended Yellow Fever Vaccine Information on Symptom Reports Following Vaccination
Condition: Vaccination
Intervention: Behavioral: Extended information on side effects
20 Recruiting Efficacy and Safety of Dengue Vaccine in Healthy Children
Conditions: Dengue Virus;   Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Diseases
Interventions: Biological: Chimeric tetravalent dengue (serotype 1, 2, 3, 4);   Biological: Inactivated Rabies virus vaccine

Previous Page Studies Shown (1-20) Next Page (21-33)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services